Symrise logo

Symrise

Last updated January 31, 2026
29
Innovation Areas
829
Inventors
14
Collaborations

Avenanthramide dicaffeoylquinic acid synergistic complex: SymriseRecent Research Landscape

Poor bioavailability and oxidation of bioactive compounds limit therapeutic efficacy. These innovations engineer specific cereal-derived polysaccharide and antioxidant synergies to enhance skin permeability and chemical stability.

What technical problems is Symrise addressing in Avenanthramide dicaffeoylquinic acid synergistic complex?

Poor bioavailability and degradation

(5)evidences

Low bioavailability of active compounds due to the skin's natural protective layers. Overcoming this resistance ensures therapeutic concentrations reach target dermal tissues.

Inadequate topical ingredient stability

(3)evidences

Compromised epidermal integrity leads to chronic inflammation and moisture loss. Restoring this barrier prevents environmental hypersensitivity and pathological dryness.

Oxidative degradation of lipids

(2)evidences

Lipid-based systems suffer from rapid oxidation and rancidity which limits product shelf life. Preventing this degradation maintains chemical integrity and functional potency.